.png)
.png)
Medcana OTCID: SFWJ Turns Up the Heat at BFCVC 3
- Feb 19
- 3 min read
By Eric J. Kemnitzer
Pharmaceutical Cannabis Expansion, Global Contracts & a $1M Market Cap?
When something smells this good, you don’t ignore it…
At BFCVC 3, CEO Gabe Diaz delivered one of the most confident, fundamentals-driven presentations we’ve seen in a long time. And let me tell you, this one was hotter than a fresh basket of Barbill wings straight out of the kitchen.
Medcana (OTCID: SFWJ) isn’t a concept company. It’s not a shell. It’s not hype.
It’s operational. Fully licensed. Harvesting. Exporting. Scaling.
Who Is Medcana?
Medcana is a pharmaceutical-grade cannabis holding company with operations in Colombia and international distribution channels forming in Australia and Germany. The company controls seven cannabis entities in Colombia, an AgTech division (Eko2o), and maintains an Australian import/distribution structure.
Their mission is simple and ambitious: become a global leader in pharmaceutical-grade cannabis production and distribution.
They currently operate on 259 acres, with greenhouse expansion underway, supported by ERP infrastructure and regulatory partnerships across multiple countries.
This isn’t theory, it’s infrastructure.
Full Production Mode
This isn’t “we’re planning to plant.”
This is:
Crop #5 harvested
3,800 plant cycles running
5,500 plant harvest target per cycle next
CBD expansion underway
Export permits in finalization
And here’s the kicker…
Their first crop produced 3.85% terpene levels which is extremely rare for greenhouse cultivation. Doctors are prescribing based on terpene profiles, not just THC. That matters.
The CEO literally described plants bending under the weight of their flower.
“Good problems to have.” -Gabe Diaz, CEO
Germany & Australia: Contracts in Motion
Medcana has signed letters of intent with German buyers, and a current German client has committed to purchasing ALL current production through year-end pending final sample approvals.
Australia distribution is ready. Export permits are in finalization. The first shipment process is long due to first-time export checks, but infrastructure is in place.
Pharma flower becomes legal in Colombia March 28th, opening local market sales as well. We believe this to be a HUGE catalyst date for Medcana and its investors.
The CBD Opportunity (Smart Move)
While everyone chases THC margins….Medcana is quietly adding:
2,500–5,500 CBD plants per cycle
Faster export approvals (3 days vs 2 months)
Lower compliance overhead
That’s capital efficiency. That’s a strong margin strategy.
The Numbers That Should Make You Look Twice
SFWJ Security Details (2/19/2026)
Market Cap: ~$1,022,503
Share Price: $0.003
Authorized Shares: 1.5B
Outstanding Shares: 340,834,462
Restricted: 171,921,444
Unrestricted: 168,913,018
Held at DTC: 167,173,510
Let that sink in.
A fully operating international cannabis exporter with signed purchase commitments…
…sitting at roughly a $1 million market cap!!
They don't need to sit in limbo like U.S. based companies, waiting for U.S. congress to get off of their ass, because they are playing in a growing open and compliant global cannabis market.
And not to mention revenue targets....
CEO guidance included:
~$50M annual revenue target (conservative)
2.5x revenue valuation estimate
Long-term valuation modeling around $125M market cap
Gabe Diaz openly stated price will not move sustainably without fundamentals, and fundamentals are coming
Why This Matters
Global cannabis market estimates:
$42.9B in 2025
27.5% CAGR through 2030
Germany expanding. Australia expanding. Brazil regulatory clarity pending. Colombia fully legalizing pharma flower.
And like I've said before, they don't need to wait for U.S. legislation.
🦬 Final Thoughts From Buffalo
Gabe Diaz has been a guest on Buffalo Fireside Chats for over a year. We’ve watched this company build in real time. He has been one of the most consistent, accomplished CEO's we've hosted and we think as he navigates his first round in the public markets, he is doing better than most.
This wasn’t a flashy presentation, it was disciplined, measured and operationally focused. And quite frankly, the OTC needs more of this!
📌 Contact & Company Info
6500 River Place Blvd, Building 7,
Suite 250
Austin, TX 78730
+1 512-554-3736
Email: info@medcana.co
X: @MedcanaCo
Ticker: OTCID: SFWJ
Follow them. Do your o
Disclaimer: This content is for informational and entertainment purposes only and is not investment advice. I am not a financial advisor. Always conduct your own due diligence and consult a licensed professional before making investment decisions. Investing in OTC securities involves significant risk, so don’t bet the wing fund on one trade.ue diligence. Watch the filings. Watch the exports.
Comments